Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyong Hwa Park

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Cancer Research and Treatment|October 8, 2009
Immunomodulation of breast cancer via tumor antigen specific Th1Mary L Disis, Kyong Hwa Park
Cancer Genetics and Cytogenetics|March 23, 2010
Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patientsJae Sook Sung, Kyong Hwa Park, Yeul Hong Kim
Human Pathology|May 5, 2018
Clonality analysis of multifocal ipsilateral breast carcinomas using X-chromosome inactivation patternsHayeon Kim, Chung-Yeul Kim, Kyong Hwa Park, et al.
Scientific Reports|April 5, 2018
Centrifugation-free extraction of circulating nucleic acids using immiscible liquid under vacuum pressureHoyoon Lee, Wonhwi Na, Chanhee Park, et al.
NPJ Precision Oncology|March 6, 2020
Precision cell-free DNA extraction for liquid biopsy by integrated microfluidicsHoyoon Lee, Chanhee Park, Wonhwi Na, et al.
Journal of Immunological Methods|September 4, 2022
Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samplesEun Jung Lee, Seungpil Jung, Kyong Hwa Park, et al.
Biochemical and Biophysical Research Communications|September 24, 2018
Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cellsYoojin Chang, Kyong Hwa Park, Ji Eun Lee, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathwaysDenise Cecil, Kyong Hwa Park, Benjamin Curtis, et al.
Genomics & Informatics|November 21, 2012
Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung CancerJae Sook Sung, Kyong Hwa Park, Seung Tae Kim, et al.
Cancer Research and Treatment|February 13, 2014
Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?Seung Tae Kim, Kyong Hwa Park, Sang Won Shin, et al.
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Cancer Research and Treatment|October 8, 2009
Immunomodulation of breast cancer via tumor antigen specific Th1Mary L Disis, Kyong Hwa Park
Cancer Genetics and Cytogenetics|March 23, 2010
Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patientsJae Sook Sung, Kyong Hwa Park, Yeul Hong Kim
Human Pathology|May 5, 2018
Clonality analysis of multifocal ipsilateral breast carcinomas using X-chromosome inactivation patternsHayeon Kim, Chung-Yeul Kim, Kyong Hwa Park, et al.
Scientific Reports|April 5, 2018
Centrifugation-free extraction of circulating nucleic acids using immiscible liquid under vacuum pressureHoyoon Lee, Wonhwi Na, Chanhee Park, et al.
NPJ Precision Oncology|March 6, 2020
Precision cell-free DNA extraction for liquid biopsy by integrated microfluidicsHoyoon Lee, Chanhee Park, Wonhwi Na, et al.
Journal of Immunological Methods|September 4, 2022
Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samplesEun Jung Lee, Seungpil Jung, Kyong Hwa Park, et al.
Biochemical and Biophysical Research Communications|September 24, 2018
Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cellsYoojin Chang, Kyong Hwa Park, Ji Eun Lee, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathwaysDenise Cecil, Kyong Hwa Park, Benjamin Curtis, et al.
Genomics & Informatics|November 21, 2012
Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung CancerJae Sook Sung, Kyong Hwa Park, Seung Tae Kim, et al.
Cancer Research and Treatment|February 13, 2014
Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?Seung Tae Kim, Kyong Hwa Park, Sang Won Shin, et al.
Pageof 20